Global Omega-3 PUFA Market is valued approximately USD 4521 million in 2019 and is anticipated to grow with a healthy growth rate of more than 8.2 % over the forecast period 2020-2027. Dietary lipids that provide a variety of health benefits are omega-3 long-chain polyunsaturated fatty acids (PUFA), including eicosatetraenoic acid (EPA) and docosahexaenoic acid (DHA). Omega-3 PUFA plays a key role in the cell membrane's anti-inflammatory mechanisms, thus improving immunity in the human body in response to infection. Omega-3 PUFA has several advantages for human wellbeing, which are gradually being implemented in industries. The healthcare sector has shifted from an emphasis on curative healthcare to preventive healthcare over the years. This development has had a huge effect on the demand for functional foods and drinks, herbal supplements and nutraceuticals that are driving the growth of the global market for omega-3 PUFA. For Instance: in February 2021, Solarvest Bioenergy Inc, , under the Eversea Brand name introduced worlds first and only Organic Omega-3 childrens fruit drop. Also, 500mg/day of DHA and EPA for healthy adults was the recommended intake suggested by the International Society for the Study of Fatty Acids and Lipids (ISSFAL) for heart health. In addition, due to its skin-benefiting qualities, omega-3 PUFA finds use in different products in the personal care industry. Thus, the escalated boom in the personal care industry drives the market growth during the forecast period. However, few of the regulations from the regulatory bodies impedes the growth of the market over the forecast period of 2020-2027.

The regional analysis of global Omega-3 PUFA market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the growing demand for EPA. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027. Factors such as strong manufacturing base, increasing middle-class population, disposable income, and health awareness would create lucrative growth prospects for the Omega-3 PUFA market across Asia-Pacific region.

Major market player included in this report are:
Cargill, Incorporated
BASF SE
Pharma Marine AS
Croda International Plc
Polaris
Pelagia AS
Omega Protein Corporation
Arista Industries
Koninklijke DSM N.V.
Arjuna Natural Pvt Ltd

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By source:
Plant
Marine
By Type:
Docosahexaenoic acid (DHA)
Eicosapentaenoic acid (EPA)
Alpha-Linolenic Acid (ALA)
Others
By Concentration:
High concentration
Medium concentration
Low concentration
By Application:
Food and beverage
Dietary supplements
Pharmaceuticals
Animal feed

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year 2017, 2018
Base year 2019
Forecast period 2020 to 2027

Target Audience of the Global Omega-3 PUFA Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors